Yuanqing got his PhD degree in nutrition at Zhejiang University in 2015. Upon graduation, he started his career in clinical nutrition research at the clinical nutrition center, Beingmate Food Research Institute. After that he engaged in clinical trial of anti-tumor targeted drugs (e.g., Ensartinib, Icotinib, and Vorolanib) at the Department of Medicine, Betta Pharmaceuticals Co., Ltd. Yuanqing joined the School of Life Sciences at Westlake University in September 2019.
Yuanqing's research mainly focuses on the interaction between dietary nutrients, gut microbiome, and host genetics on the etiology of metabolic disorders (e.g., dyslipidemia, cancer, obesity, and type 2 diabetes) using data from multi-omics (genomics, proteomics, metabolomics and metagenomics). He is now involved in several prospective cohort studies to understand the role of nutrients, dietary pattern, lifestyle factors and gut microbiome on risk of metabolic disorders, the effect of parental nutrition on offspring health, as well as the impact of early-life exposures on gut microbiome and long-term health issues (e.g., childhood obesity). He is also interested in exploring potential causal association between nutritional biomarkers and metabolic diseases via Mendelian randomization and discovering the underlying mechanisms through animal studies.
(# contribute equally; * corresponding author)
Xu FZ#, Fu YQ#, Sun TY, Jiang ZL, Miao ZL, Shuai ML, Gou WL, Ling CW, Yang J, Wang J, Chen YM, Zheng JS. The interplay between host genetics and the gut microbiome reveals common and distinct microbiome features for complex human diseases. Microbiome 2020; (in press)
Fu YQ#, Gou WL#, Hu WS#, Mao YY, Tian YY, Liang XX, Guan YH, Huang T, Li KL, Guo XF, Liu HJ, Li D, Zheng JS. Integration of an interpretable machine learning algorithm to identify early life risk factors of childhood obesity among preterm infants: a prospective birth cohort. BMC Med. 2020;18(1):184
Lu S#, Fu YQ#, Wu YY, Mao AF, Xu MY, Zheng GY, Cai FC, Wang XH, Shi MQ, Hu WS*. Mediating Effects of Maternal Blood Triglycerides on the Relationship between Prepregnancy Body Mass Index and Fetal Macrosomia. J Pediatr. 2020:S0022-3476(20)30854-4.
Gou WL#, Fu YQ#, Yue L#, Chen GD#, Cai X#, Shuai ML#, Xu FZ#, Yi X, Chen H, Zhu YJ, Xiao ML, Jiang ZL, Miao ZL, Xiao CM, Shen B, Wu XM, Zhao HH, Ling WH, Wang J, Chen YM, Guo TN, Zheng JS*. Gut microbiota may underlie the predisposition of healthy individuals to COVID-19. medRxiv 2020; (under review; doi:10.1101/2020.04.22.20076091)
Wan Yi, Fu YQ, Wang FL, Sinclair AJ, Li D*. Protective Effects of a Lipid Extract From Hard-Shelled Mussel ( Mytilus coruscus) on Intestinal Integrity After Lipopolysaccharide Challenge in Mice. Nutrients 2018; 10(7):860.
Fu YQ, Liu X, Zhou B, Jiang AC, Chai LY*. An updated review of worldwide levels of docosahexaenoic and arachidonic acid in human breast milk by region. Public Health Nutrition 2016; 19(15):2675-87.
Wang FL, Fu YQ, Cai WW, Sinclair AJ, Li D*. Anti-inflammatory activity and mechanisms of a lipid extract from hard-shelled mussel (Mytilus coruscus) in mice with dextran sulphate sodium-induced colitis. Journal of Functional Foods 2016; 23:389-99.
Fu YQ, Li GP, Zhang XH, Xing GY, Yang LF, Hu XJ, Li D*. Lipid extract from hard-shelled mussel (Mytilus coruscus) improves clinical conditions of patients with rheumatoid arthritis: a randomized controlled trial. Nutrients 2015; 7(1):625-45.
Fu YQ, Zheng JS, Yang B, Li D*. Effect of individual omega-3 fatty acids on the risk of prostate cancer: a systematic review and dose-response meta-analysis of prospective cohort studies. Journal of Epidemiology 2015;25(4):261-74.
Fu YQ, Zhang Y, Hu HY, Chen Y, Wang R, Li D*, Liu SB*. Design and straightforward synthesis of novel galloyl phytosterols with excellent antioxidant activity. Food Chemistry 2014; 163: 171–77.
Li GP, Fu YQ, Zheng JS, Li Duo*. Anti-inflammatory Activity and Mechanism of a Lipid Extract From Hard-Shelled Mussel (Mytilus Coruscus) on Chronic Arthritis in Rats. Marine Drugs 2014: 12(2):568-88.
Fu YQ, Hong S, Li D, Liu SB*. Novel chemical synthesis of ginkgolic acid (13:0) and evaluation of its tyrosinase inhibitory activity. Journal of Agricultural and Food Chemistry 2013; 61 (22): 5347–52.